These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19805557)

  • 1. Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical origin.
    Locke JB; Hilgers M; Shaw KJ
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5275-8. PubMed ID: 19805557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700).
    Locke JB; Hilgers M; Shaw KJ
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5265-74. PubMed ID: 19752277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated linezolid resistance in clinical cfr-positive Staphylococcus aureus isolates is associated with co-occurring mutations in ribosomal protein L3.
    Locke JB; Morales G; Hilgers M; G C K; Rahawi S; José Picazo J; Shaw KJ; Stein JL
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5352-5. PubMed ID: 20837755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyphyletic emergence of linezolid-resistant staphylococci in the United States.
    Wong A; Reddy SP; Smyth DS; Aguero-Rosenfeld ME; Sakoulas G; Robinson DA
    Antimicrob Agents Chemother; 2010 Feb; 54(2):742-8. PubMed ID: 19933808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships of diverse oxazolidinones for linezolid-resistant Staphylococcus aureus strains possessing the cfr methyltransferase gene or ribosomal mutations.
    Locke JB; Finn J; Hilgers M; Morales G; Rahawi S; G C K; Picazo JJ; Im W; Shaw KJ; Stein JL
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5337-43. PubMed ID: 20837751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of linezolid-resistant Staphylococcus aureus with 23S rRNA and novel L4 riboprotein mutations in a cystic fibrosis patient in Spain.
    Román F; Roldán C; Trincado P; Ballesteros C; Carazo C; Vindel A
    Antimicrob Agents Chemother; 2013 May; 57(5):2428-9. PubMed ID: 23459489
    [No Abstract]   [Full Text] [Related]  

  • 7. Mutation in the L3 Ribosomal Protein Could Be Associated with Risk of Selection of High-Level Linezolid-Resistant Staphylococcus epidermidis Strains.
    Rouard C; Aslangul E; Rivière A; Deback C; Butel MJ; Doucet-Populaire F; Bourgeois-Nicolaos N
    Microb Drug Resist; 2017 Jun; 23(4):462-467. PubMed ID: 27754824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linezolid dependence in Staphylococcus epidermidis bloodstream isolates.
    Pournaras S; Ntokou E; Zarkotou O; Ranellou K; Themeli-Digalaki K; Stathopoulos C; Tsakris A
    Emerg Infect Dis; 2013 Jan; 19(1):129-32. PubMed ID: 23260390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of linezolid resistance among Staphylococci in a tertiary hospital.
    Quiles-Melero I; Gómez-Gil R; Romero-Gómez MP; Sánchez-Díaz AM; de Pablos M; García-Rodriguez J; Gutiérrez A; Mingorance J
    J Clin Microbiol; 2013 Mar; 51(3):998-1001. PubMed ID: 23269737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of linezolid resistance in staphylococci and enterococci isolated from two teaching hospitals in Shanghai, China.
    Tian Y; Li T; Zhu Y; Wang B; Zou X; Li M
    BMC Microbiol; 2014 Nov; 14():292. PubMed ID: 25420718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tedizolid for the management of human infections: in vitro characteristics.
    Locke JB; Zurenko GE; Shaw KJ; Bartizal K
    Clin Infect Dis; 2014 Jan; 58 Suppl 1():S35-42. PubMed ID: 24343830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and epidemiologic characteristics of linezolid-resistant coagulase-negative staphylococci at a tertiary care hospital.
    Kosowska-Shick K; Julian KG; McGhee PL; Appelbaum PC; Whitener CJ
    Diagn Microbiol Infect Dis; 2010 Sep; 68(1):34-9. PubMed ID: 20727467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances.
    Besier S; Ludwig A; Zander J; Brade V; Wichelhaus TA
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1570-2. PubMed ID: 18212098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of linezolid-resistant CoNS isolates in Japan.
    Takaya A; Kimura A; Sato Y; Ishiwada N; Watanabe M; Matsui M; Shibayama K; Yamamoto T
    J Antimicrob Chemother; 2015 Mar; 70(3):658-63. PubMed ID: 25381168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to linezolid in Staphylococcus spp. clinical isolates associated with ribosomal binding site modifications: novel mutation in domain V of 23S rRNA.
    Musumeci R; Calaresu E; Gerosa J; Oggioni D; Bramati S; Morelli P; Mura I; Piana A; Are BM; Cocuzza CE
    New Microbiol; 2016 Oct; 39(4):269-273. PubMed ID: 27727405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of linezolid resistance among coagulase-negative staphylococci determined by whole-genome sequencing.
    Tewhey R; Gu B; Kelesidis T; Charlton C; Bobenchik A; Hindler J; Schork NJ; Humphries RM
    mBio; 2014 May; 5(3):e00894-14. PubMed ID: 24915435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase.
    Arias CA; Vallejo M; Reyes J; Panesso D; Moreno J; Castañeda E; Villegas MV; Murray BE; Quinn JP
    J Clin Microbiol; 2008 Mar; 46(3):892-6. PubMed ID: 18174304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linezolid-resistant clinical isolates of enterococci and Staphylococcus cohnii from a multicentre study in China: molecular epidemiology and resistance mechanisms.
    Chen H; Wu W; Ni M; Liu Y; Zhang J; Xia F; He W; Wang Q; Wang Z; Cao B; Wang H
    Int J Antimicrob Agents; 2013 Oct; 42(4):317-21. PubMed ID: 23880167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci.
    Rodríguez-Avial I; Culebras E; Betriu C; Morales G; Pena I; Picazo JJ
    J Antimicrob Chemother; 2012 Jan; 67(1):167-9. PubMed ID: 21954458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed development of linezolid resistance in Staphylococcus aureus following exposure to low levels of antimicrobial agents.
    Miller K; O'Neill AJ; Wilcox MH; Ingham E; Chopra I
    Antimicrob Agents Chemother; 2008 Jun; 52(6):1940-4. PubMed ID: 18378719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.